TPG GP A, LLC
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 13, 2026), TPG GP A, LLC reported 10 stock positions worth $2.7 billion. Its top holding was Lifestance Health (LFST) at 42.1% of the portfolio, followed by Life Time (LTH, 17.6%) and Beta Technologies Class A (BETA, 17.2%). Compared with Q3 2025, it opened 1 new position. The biggest buy was a new position in Beta Technologies Class A (BETA).
- Most Recent 13F
- Q2 2026
- Location
- FORT WORTH, TX
- CIK
- 0001903793
- Portfolio Value
- $2.7B (Q4 2025)
- SEC Filing
- 0001999371-26-003325 ↗ filed Feb 13, 2026
Holdings Value
Holdings 10 stocks · $2.7B
| LFST Lifestance Health Group Inc. | 42.11% | 160,711,618 | $1.1B | No change |
| LTH Life Time Group Holdings Inc. | 17.64% | 17,830,652 | $473.9M | No change |
| BETA Beta Technologies Inc. Class A | 17.21% | 16,395,435 | $462.5M | New |
| SION Sionna Therapeutics Inc. | 10.33% | 6,744,962 | $277.5M | No change |
| AMRX Amneal Pharmaceuticals Inc. | 5.78% | 12,328,767 | $155.3M | No change |
| CBLL Ceribell Inc. | 3.24% | 3,967,422 | $87.0M | No change |
| BCAX Bicara Therapeutics Inc. | 1.89% | 3,010,425 | $50.7M | No change |
| ALLO Allogene Therapeutics Inc. | 0.95% | 18,716,306 | $25.6M | No change |
| TRTX TPG Re Finance Trust Inc. | 0.77% | 2,392,863 | $20.6M | No change |
| RLYB Rallybio Corp. | 0.08% | 3,028,414 | $2.1M | No change |
Portfolio Sells Q3 2025 → Q4 2025
| None this quarter. | |||
Portfolio Buys Q3 2025 → Q4 2025
| BETA Beta Technologies Inc. Class A | New | 17.21% | +17.21 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 56 | $4.7B | LFST, SPCX, JXN, LTH, SION |
| Q1 2026 | 49 | $3.4B | LFST, JXN, LTH, SION, BETA |
| Q4 2025 | 10 | $2.7B | LFST, LTH, BETA, SION, AMRX |
| Q3 2025 | 9 | $1.8B | LFST, LTH, SION, AMRX, BCAX |
| Q2 2025 | 9 | $1.9B | LFST, LTH, SION, AMRX, CBLL |
| Q1 2025 | 27 | $5.0B | LFST, LTH, VIK, TTAN, PEGA |
| Q4 2024 | 31 | $6.2B | VIK, LFST, LTH, TTAN, MTN |
| Q3 2024 | 35 | $5.9B | VIK, LFST, LTH, PGRU, UNH |
| Q2 2024Amended | 34 | $6.4B | VIK, LTH, LFST, LW, PGRU |
| Q1 2024Amended | 34 | $5.2B | LFST, LTH, Nextracker Inc, Progyny Inc, ELV |